IA
SANA icon

IFP Advisors’s Sana Biotechnology SANA Stock Holding History

IFP Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4K Buy
5,545
+145
+3% +$467 ﹤0.01% 2999
2026
Q1 		$15.6K Sell
5,400
-399
-7% -$1.57K ﹤0.01% 2920
2025
Q4 		$23.6K Hold
5,799
– – ﹤0.01% 2639
2025
Q3 		$20.6K Buy
5,799
+3,898
+205% +$14.1K ﹤0.01% 2565
2025
Q2 		$5.19K Buy
+1,901
New +$3.92K ﹤0.01% 3357
2025
Q1 		– Sell
-9
Closed -$15 – 4589
2024
Q4 		$15 Buy
+9
New +$27 ﹤0.01% 4495

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

IFP Advisors's SANA Position: Q2 2026 in Review

IFP Advisors increased its Sana Biotechnology (SANA) stake by 2.7% in Q2 2026, buying an estimated $467 and bringing the position to 5,545 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2999.

IFP Advisors first reported a position in SANA in Q4 2024 and has held it in 6 quarters since. The position peaked at $23.6K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • IFP Advisors held 5,545 shares of Sana Biotechnology worth $19.4K as of Q2 2026.
  • IFP Advisors bought 145 Sana Biotechnology shares in Q2 2026, an estimated $467.
  • Sana Biotechnology made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2999 holding.
  • IFP Advisors first reported a position in Sana Biotechnology in Q4 2024 and has held it in 6 quarters since.
  • IFP Advisors's Sana Biotechnology position peaked at $23.6K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.